Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 76051-76100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05804136
Duramesh™ vs Polydioxanone Suture for Laparotomy Closure
NARecruiting
230 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05736978
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
PHASE2Recruiting
58 participants
Started: Mar 31, 2023 · Completed: Mar 15, 2027
2 conditions1 sponsor4 locations
NCT05595603
Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
PHASE2Recruiting
153 participants
Started: Mar 31, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05734313
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
NARecruiting
94 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
2 conditions3 sponsors2 locations
NCT05452733
Toward a Real-time Access to Sleepers' Mental Content
NARecruiting
200 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
3 conditions2 sponsors1 location
NCT05540288
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
PHASE3Recruiting
266 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor13 locations
NCT06031181
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
PHASE3Recruiting
390 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT05794178
Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
NARecruiting
360 participants
Started: Mar 31, 2023 · Completed: Nov 30, 2026
2 conditions2 sponsors2 locations
NCT05616325
Long-term Ovarian Fertility in Patients Treated for Lymphoma.
N/ANot yet recruiting
270 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2029
1 condition2 sponsors0 locations
NCT05793554
CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery
N/ARecruiting
600 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
3 conditions12 sponsors1 location
NCT05723250
Care Coordination Educational Intervention Study for Patients from Rural Areas with Early Stage Cancer
NARecruiting
40 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05779813
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
N/ARecruiting
200 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2035
2 conditions1 sponsor1 location
NCT06864000
Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy
N/ARecruiting
100 participants
Started: Mar 31, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05665790
Primary Lesion Treatment for Bone Metastases
NANot yet recruiting
400 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT05748366
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
NARecruiting
60 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05753566
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
PHASE2Recruiting
96 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors2 locations
NCT05528900
A Multicentre French Prospective Study of Children With Food Protein Induced Enterocolitis Syndrome in Its Acute Form
NARecruiting
600 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor19 locations
NCT05562167
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
PHASE2Recruiting
75 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06875245
Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals
PHASE4Recruiting
100 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05796973
Measuring Oncological Value of Exercise and Statin
PHASE3Recruiting
240 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
12 conditions5 sponsors1 location
NCT06886958
Spectral CT Protocol Optimization for Atherosclerotic Plaque CharacterizatION
N/AActive, not recruiting
100 participants
Started: Mar 31, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT05774951
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
PHASE3Recruiting
4,300 participants
Started: Mar 31, 2023 · Completed: May 29, 2036
1 condition1 sponsor722 locations
NCT05282966
Assessment of QSant™ for Underlying Allograft Rejection
N/ANot yet recruiting
4,000 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor0 locations
NCT05676437
Knee Arthroplasty Instability Study
N/ANot yet recruiting
100 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection
PHASE3Recruiting
500 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2032
6 conditions1 sponsor17 locations
NCT05783531
Accessing Innovative Mental Health Services for Depression in Vietnam
NANot yet recruiting
336 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
2 conditions3 sponsors0 locations
NCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
N/ARecruiting
143 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05723107
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1Recruiting
15 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05508256
CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
PHASE4Recruiting
1,548 participants
Started: Mar 31, 2023 · Completed: Jul 31, 2027
3 conditions4 sponsors1 location
NCT02994498
Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
PHASE1/PHASE2Not yet recruiting
33 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05769205
MRI in Ovarian Tumors
NANot yet recruiting
25 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT05682976
Ophthalmological Adverse Events of Tralokinumab in AD
N/ANot yet recruiting
100 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors11 locations
NCT05584709
Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
34 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05665439
Local Treatment for Bone Metastases
NANot yet recruiting
348 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT05772390
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
PHASE2Recruiting
68 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2032
2 conditions1 sponsor1 location
NCT05776940
Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
PHASE3Not yet recruiting
116 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT05317403
Venetoclax to Augment Epigenetic Modification and Chemotherapy
PHASE1Recruiting
40 participants
Started: Mar 31, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05576376
Calcaneal Osteotomy for Intractable Plantar Fasciitis
NANot yet recruiting
60 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor0 locations
NCT05718232
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
PHASE3Not yet recruiting
136 participants
Started: Mar 31, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05887011
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
N/ARecruiting
2,000 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor41 locations
NCT05774743
Pediatric Anesthesia Consent - Visual Aids
NARecruiting
140 participants
Started: Mar 31, 2023 · Completed: May 1, 2025
2 conditions1 sponsor1 location
NCT05714345
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
PHASE2Active, not recruiting
70 participants
Started: Mar 31, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor2 locations
NCT06391788
Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy
NARecruiting
132 participants
Started: Mar 31, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT05869968
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
N/ARecruiting
140 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2027
5 conditions3 sponsors1 location
NCT05664035
SPAD in Adult Patients
N/ANot yet recruiting
99 participants
Started: Mar 31, 2023 · Completed: Jun 30, 2026
2 conditions5 sponsors0 locations
NCT05796531
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
NARecruiting
155 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT05787418
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
PHASE3Enrolling by invitation
1,200 participants
Started: Mar 31, 2023 · Completed: Apr 1, 2026
1 condition1 sponsor2 locations
NCT05602376
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
NARecruiting
3,642 participants
Started: Mar 31, 2023 · Completed: May 31, 2027
3 conditions4 sponsors2 locations
NCT05759325
An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma
N/ANot yet recruiting
100 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05786430
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib
PHASE2Not yet recruiting
87 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location